BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8115001)

  • 21. Medulloblastoma demonstrating multipotent differentiation: case report.
    Sakata H; Kanamori M; Watanabe M; Kumabe T; Tominaga T
    Brain Tumor Pathol; 2008; 25(1):39-43. PubMed ID: 18415665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glial fibrillary acidic protein in medulloblastoma.
    Mannoji H; Takeshita I; Fukui M; Ohta M; Kitamura K
    Acta Neuropathol; 1981; 55(1):63-9. PubMed ID: 7348008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medulloblastoma with glial and rhabdomyoblastic differentiation. A myoglobin and glial fibrillary acidic protein immunohistochemical and ultrastructural study.
    Dickson DW; Hart MN; Menezes A; Cancilla PA
    J Neuropathol Exp Neurol; 1983 Nov; 42(6):639-47. PubMed ID: 6355400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contributions of immunohistochemistry to the problem of differentiation in medulloblastoma.
    Giordana MT; Mauro A; Migheli A; Schiffer D
    Ital J Neurol Sci; 1983 Dec; 4(4):411-5. PubMed ID: 6674239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent glial and neuronal differentiation in a cerebellar medulloblastoma in an organ culture system: in vitro occurrence of synaptic ribbons.
    Herman MM; Rubinstein LJ
    Acta Neuropathol; 1984; 65(1):10-24. PubMed ID: 6516798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuron-associated class III beta-tubulin, tau, and MAP2 in the D-283 Med cell line and in primary explants of human medulloblastoma.
    Vinores SA; Herman MM; Katsetos CD; May EE; Frankfurter A
    Histochem J; 1994 Aug; 26(8):678-85. PubMed ID: 7527016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medullocytoma (lipidized medulloblastoma). A cerebellar neoplasm of adults with favorable prognosis.
    Giangaspero F; Cenacchi G; Roncaroli F; Rigobello L; Manetto V; Gambacorta M; Allegranza A
    Am J Surg Pathol; 1996 Jun; 20(6):656-64. PubMed ID: 8651344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
    Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
    Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar "neuroblastoma": nosology as it relates to medulloblastoma.
    Pearl GS; Takei Y
    Cancer; 1981 Feb; 47(4):772-9. PubMed ID: 7226024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipidized mature neuroectodermal tumour of the cerebellum with myoid differentiation.
    González-Cámpora R; Weller RO
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):397-402. PubMed ID: 9821171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glial fibrillary acidic protein and neurofilament protein in medulloblastoma].
    Tohyama T; Kubo O; Katahira M; Sakairi M; Tajika T; Tajika Y; Kitamura K
    No Shinkei Geka; 1988 Oct; 16(11):1243-50. PubMed ID: 3145467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of medulloblastoma 19 years after the initial diagnosis.
    Amagasaki K; Yamazaki H; Koizumi H; Hashizume K; Sasaguchi N
    Childs Nerv Syst; 1999 Sep; 15(9):482-5. PubMed ID: 10502011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
    Kenigsberg RL; Hong Y; Yao H; Lemieux N; Michaud J; Tautu C; Théorêt Y
    Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 26-year-old man with a cerebellar mass.
    Jain D; Roy S; Bhalla S; Mehta VS
    Brain Pathol; 2013 Jan; 23(1):109-12. PubMed ID: 23217008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal differentiation associated with Gli3 expression predicts favorable outcome for patients with medulloblastoma.
    Miyahara H; Natsumeda M; Yoshimura J; Ogura R; Okazaki K; Toyoshima Y; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2014 Feb; 34(1):1-10. PubMed ID: 23889567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large cell/anaplastic medulloblastoma with myogenic, melanotic and neuronal differentiation: a case report of a rare tumor.
    Fathaddin AA; Bakhash EA; Sabbagh AJ; Al-Dandan SW
    Indian J Pathol Microbiol; 2014; 57(2):294-7. PubMed ID: 24943770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Establishment and biological characterization of human medulloblastoma cell lines].
    Yamada M; Shimizu K; Tamura K; Okamoto Y; Matsui Y; Moriuchi S; Park K; Mabuchi E; Yamamoto K; Hayakawa T
    No To Shinkei; 1989 Jul; 41(7):695-702. PubMed ID: 2818910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation in the medulloblastoma. A histological and immunohistochemical study.
    Burger PC; Grahmann FC; Bliestle A; Kleihues P
    Acta Neuropathol; 1987; 73(2):115-23. PubMed ID: 3604579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinical and pathological study of cerebellar medulloblastoma in adult patients].
    Li N; Zhu J; Ma H
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):213-5. PubMed ID: 11244985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice.
    Jacobsen PF; Jenkyn DJ; Papadimitriou JM
    J Neuropathol Exp Neurol; 1985 Sep; 44(5):472-85. PubMed ID: 2993532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.